<html>
<head>PUBMED IDs for GLCE</head>
<body bgcolor='#C5F0F2'><h1>GLCE</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15853773/'>The human D-glucuronyl C5-epimerase gene is transcriptionally activated through the beta-catenin-TCF4 pathway.</a> April 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18463796/'>Hydrogen peroxide as a potential mediator of the transcriptional regulation of heparan sulphate biosynthesis in keratinocytes.</a> May 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22805760/'>The TCF4/Î²-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.</a> January 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22968430/'>miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.</a> April 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24264315/'>D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.</a> June 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24403231/'>Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.</a> September 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24782989/'>Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.</a> May 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26120938/'>Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26527314/'>Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.</a> October 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27699767/'>Glucuronic Acid Epimerase (GLCE) Variant rs3865014 (A&gt;G) Is Associated with BMI, Blood Hemoglobin, Hypertension, and Cerebrovascular Events, the TAMRISK Study.</a> October 5  2016<br></body></html>
